ARCHIVES

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

SWOG Releases RFA For Use Of Biorepository

November 12, 2010

ASC Survey Leads to Strategic Plan Development, Office In Washington

June 9, 1989

AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.

April 14, 2006

In Brief: GM Cancer Research Foundation Awards Three Prizes to Five Cancer Researchers

May 5, 2000

Oncology Management: US Oncology To Conduct Up To 5 Studies Of PG-TXL In Colorectal, Lung Cancers

June 1, 2001

Cancer Prevention; BCPT Enrollment Final At 13,000 After 5 Years

July 4, 1997